Article Information
History
- May 24, 2019.
Article Versions
- Version 1 (January 16, 2019 - 05:45).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Ruth A. Pumroy1,*,
- Amrita Samanta1,*,
- Yuhang Liu2,*,
- Taylor E.T. Hughes1,
- Siyuan Zhao3,
- Yevgen Yudin3,
- Kevin W. Huynh4,
- Z. Hong Zhou4,
- Tibor Rohacs3,
- Seungil Han2,# and
- Vera Y. Moiseenkova-Bell1,#
- 1Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
- 2Pfizer Research and Development, Groton, Connecticut 06340, USA
- 3Department of Pharmacology, Physiology and Neuroscience, New Jersey Medical School, Rutgers University, Newark, New Jersey 07103, USA
- 4California NanoSystems Institute, University of California, Los Angeles, California 90095, USA
- ↵#Correspondence and requests for materials should be addressed to S.H. (email: seungil.han{at}pfizer.com), V.M.-B. (email: vmb{at}pennmedicine.upenn.edu)
↵* These authors contributed equally: Ruth A. Pumroy, Amrita Samanta, Yuhang Liu